Found an issue? Give us feedback

Link to

shareShare

uploadDeposit

codeEmbed

downloadDownload

Select content type to embed

All Research products

arrow_drop_down

<script type="text/javascript">
<!--
document.write('<div id="oa_widget"></div>');
document.write('<script type="text/javascript" src="https://www.openaire.eu/index.php?option=com_openaire&view=widget&format=raw&projectId=aka_________::a77d299ee00dfee2de17de8fcd02c69a&type=result"></script>');
-->
</script>

COPY SCRIPT

For further information contact us at helpdesk@openaire.eu

Bioreversible prodrugs for the treatment of leishmaniasis

assignment_turned_inproject01 Aug 2002(Started)-31 Dec 2004(Ended)Closed

Funder: Research Council of FinlandProject code: 80070 Call for proposal: Tutkijatohtoripaikat/yksittäiset tutkijat TT

Funder Contribution: 84,800 EUR

Bioreversible prodrugs for the treatment of leishmaniasis

- Summary
- DMPs

Partners

UEF

Data Management Plans

Start a new DMP in Argos

Found an issue? Give us feedback

Select content type to embed

All Research products

arrow_drop_down

<script type="text/javascript">
<!--
document.write('<div id="oa_widget"></div>');
document.write('<script type="text/javascript" src="https://www.openaire.eu/index.php?option=com_openaire&view=widget&format=raw&projectId=aka_________::a77d299ee00dfee2de17de8fcd02c69a&type=result"></script>');
-->
</script>

COPY SCRIPT

For further information contact us at helpdesk@openaire.eu

Bioreversible prodrugs for the treatment of leishmaniasis

Bioreversible prodrugs for the treatment of leishmaniasis

Loading